MRK

Merck (MRK) closed the most recent trading day at $92.25, moving +1.84% from the previous trading session.

We believe investors with a long-term horizon should stay invested in MRK stock, while short-term investors should consider selling the...

It's been a rough start to 2025 for Merck (MRK 2.08%) shareholders following a less-than-stellar fourth-quarter earnings report. Even as...

Buying a dividend stock at a cheap valuation can be a great move for several reasons. If a stock has...

Big Tech and pharmaceutical companies are accelerating the implementation of artificial intelligence in the healthcare industry. Just last month, AWS...

NEW YORK, Feb. 12, 2025 (GLOBE NEWSWIRE) -- The following statement is being issued by Levi & Korsinsky, LLP: To:...

Media personality Jim Cramer often makes bold statements about companies and a lot of times, he proves himself correct.

Merck & Co . (NYSE:MRK) is a prominent American multinational pharmaceutical company many investors know for its brand-name drugs such...

Merck & Co. Inc. (NYSE: MRK) is rewarding its shareholders once again with a quarterly dividend of $0.81 per share,...

Merck (MRK) closed at $99.72 in the latest trading session, marking a +0.59% move from the prior day.